San Diego-based mostly Viking Therapeutics marked alone as a serious competitor in the weight loss drug current market in February immediately after revealing promising info from a mid-stage trial of experimental drug VK2735, which advised it rivaled—and outperformed—Novo and Lilly drugs when specified as a weekly injection and in March the com